10-Q Filing

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. CIK: 1350156 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001262463-23-000120`
Period End Date	20230831
Filing Date	20231013
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	paxh8312023q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 38 Income Statement 26 Cash Flow Statement 31 Stockholders Equity 10

Balance Sheet 38 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.77M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.77M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.77M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.77M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$355.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$6.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$355.00	USD	Point-in-time
Total assets	`Assets`	$6.00	USD	Point-in-time
Total assets	`Assets`	$355.00	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$158.35K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$155.67K	USD	Point-in-time
Liability for unissued shares	`LiabilityForUnissuedSharesCurrent`	$134.79K	USD	Point-in-time
Liability for unissued shares	`LiabilityForUnissuedSharesCurrent`	$134.79K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.30M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.34M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, 75,000,000 shares authorized. 19,767,698 shares issued and outstanding	`CommonStockValue`	$19.77K	USD	Point-in-time
Common Stock, $0.001 par value, 75,000,000 shares authorized. 19,767,698 shares issued and outstanding	`CommonStockValue`	$19.77K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.66M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.66M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.20K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.20K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.03M	USD	Point-in-time
Total Stockholders Deficit	`StockholdersEquity`	$-2.34M	USD	Point-in-time
Total Stockholders Deficit	`StockholdersEquity`	$-2.14M	USD	Point-in-time
Total Stockholders Deficit	`StockholdersEquity`	$-2.30M	USD	Point-in-time
Total Stockholders Deficit	`StockholdersEquity`	$-2.18M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$355.00	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$6.00	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net loss per share - basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Weighted average number of common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	19.77M	shares	1 Quarter
Weighted average number of common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	19.77M	shares	1 Quarter
Weighted average number of common shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	19.77M	shares	1 Quarter
Weighted average number of common shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	19.77M	shares	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of Sales	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Cost of Sales	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Gross Profit	`GrossProfit`	-	USD	1 Quarter
Gross Profit	`GrossProfit`	-	USD	1 Quarter
Professional	`ProfessionalFees`	$7.71K	USD	1 Quarter
Professional	`ProfessionalFees`	$2.50K	USD	1 Quarter
Office and administration	`GeneralAndAdministrativeExpense`	$1.58K	USD	1 Quarter
Office and administration	`GeneralAndAdministrativeExpense`	$1.69K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.27K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.52K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$37.35K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$40.92K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-37.35K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-40.92K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-40.92K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-37.35K	USD	1 Quarter

Cash Flow Statement 31 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-40.92K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.35K	USD	1 Quarter
Increase in accounts payable and accrued liabilities - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$30.00K	USD	1 Quarter
Increase in accounts payable and accrued liabilities - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$30.00K	USD	1 Quarter
Increase in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.68K	USD	1 Quarter
Increase in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-5.94K	USD	1 Quarter
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.29K	USD	1 Quarter
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.60K	USD	1 Quarter
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds from the issuance of liability for unissued shares	`ProceedsFromIssuanceOfLiabilityForUnissuedShares`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.23K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.95K	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$349.00	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-59.00	USD	1 Quarter
Cash, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$200.00	USD	Point-in-time
Cash, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00	USD	Point-in-time
Cash, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.00	USD	Point-in-time
Cash, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$355.00	USD	Point-in-time
Cash, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$200.00	USD	Point-in-time
Cash, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00	USD	Point-in-time
Cash, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.00	USD	Point-in-time
Cash, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$355.00	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Conversion of Accounts payable and accrued liabilities - related party to Promissory note - related party	`ConversionOfAccountsPayableAndAccruedLiabilitiesRelatedPartyToPromissoryNoteRelatedParty`	-	USD	1 Quarter
Conversion of Accounts payable and accrued liabilities - related party to Promissory note - related party	`ConversionOfAccountsPayableAndAccruedLiabilitiesRelatedPartyToPromissoryNoteRelatedParty`	-	USD	1 Quarter
Conversion of Advances - related party to Promissory note - related party	`ConversionOfAdvancesRelatedPartyToPromissoryNoteRelatedParty`	-	USD	1 Quarter
Conversion of Advances - related party to Promissory note - related party	`ConversionOfAdvancesRelatedPartyToPromissoryNoteRelatedParty`	-	USD	1 Quarter

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$-2.34M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-2.14M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-2.30M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-2.18M	USD	Point-in-time
Net loss and comprehensive loss	`NetIncomeLoss`	$-40.92K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-37.35K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$-2.34M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-2.14M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-2.30M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-2.18M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.